ClinicalTrials.Veeva

Menu

Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)

T

Tabriz University

Status and phase

Completed
Phase 2
Phase 1

Conditions

Central Serous Chorioretinopathy

Treatments

Drug: omeprazole, Amoxicillin, metronidazole

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Etiology of ICSCR is not known however recent studies regard the role of immunologic and infectious processes in the pathogenesis of ICSCR.one of these hypothesis is the role of helicobacter pylori in the pathogenesis of ICSCR so perhaps treatment of h pylori have positive effect on the remission of ICSCR.

Full description

we will choose 50 cases of patients with ICSCR who are infected with h.pylori.25 cases will receive anti h.pylori regiment and 25 cases as controls will receive no medication.then we will compare the time of submacular fluid resorption and macular thickness and visual acuity among these two groups.

Enrollment

50 patients

Sex

All

Ages

28 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • the persons who are infected with helicobacter pylori and have ICSCR

Exclusion criteria

  • history of previous eye surgery ,to have indication of laser therapy,corticosteroid therapy,pregnancy,

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

1
Active Comparator group
Description:
Oral Amoxicillin Capsule Metronidazole Tablet Omeprazole Capsule
Treatment:
Drug: omeprazole, Amoxicillin, metronidazole
2
No Intervention group
Description:
No medical treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems